Meidan Ying
- Molecular Biology top 5%
- Cancer Research top 2%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 5%
- Topics
- Ubiquitin and proteasome pathways (24 papers)Retinoids in leukemia and cellular processes (17 papers)Acute Myeloid Leukemia Research (12 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationNature Communications
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Meidan Ying
91 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 121
- Molecular Biology 2.2k
- Cancer Research 813
- Oncology 705
- Pulmonary and Respiratory Medicine 575
- Immunology 493
Countries citing papers authored by Meidan Ying
This map shows the geographic impact of Meidan Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meidan Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meidan Ying more than expected).
Fields of papers citing papers by Meidan Ying
This network shows the impact of papers produced by Meidan Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meidan Ying. The network helps show where Meidan Ying may publish in the future.
Co-authorship network of co-authors of Meidan Ying
This figure shows the co-authorship network connecting the top 25 collaborators of Meidan Ying. A scholar is included among the top collaborators of Meidan Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meidan Ying. Meidan Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | 58 | |
| 7 | 10 | |
| 8 | 133 | |
| 9 | 16 | |
| 10 | Inhibitor of DNA binding 1 (Id1) mediates stemness of colorectal cancer cells through the Id1-c-Myc-PLAC8 axis via the Wnt/β-catenin and Shh signaling pathways | 2 |
| 11 | 132 | |
| 12 | 34 | |
| 13 | 121 | |
| 14 | 47 | |
| 15 | 38 | |
| 16 | 57 | |
| 17 | 36 | |
| 18 | 13 | |
| 19 | 20 | |
| 20 | 31 |
About Meidan Ying
Meidan Ying is a scholar working on Cancer Research, Hematology and Molecular Biology, having authored 95 papers that have together received 3.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (24 papers), Retinoids in leukemia and cellular processes (17 papers) and Acute Myeloid Leukemia Research (12 papers). The work is most often cited by research in Cancer Research (813 citations), Molecular Biology (2.2k citations) and Oncology (705 citations). Meidan Ying has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Qiaojun He, Bo Yang, Ji Cao, Hong Zhu, Xuejing Shao, Yuan Meng, Rong Dong, Fangjie Yan, Jiang Li and Tao Yuan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.